US 12403183
Factor VIII polypeptide formulations
granted A61KA61K38/37A61P
Quick answer
US patent 12403183 (Factor VIII polypeptide formulations) held by BIOVERATIV THERAPEUTICS INC. expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BIOVERATIV THERAPEUTICS INC.
- Grant date
- Tue Sep 02 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 44
- CPC classes
- A61K, A61K38/37, A61P, A61P43/00, A61P7/00